Immunonephelometric Determination of the Apolipoprotein A-II by Hafner, G. et al.
Hafner et al.: Immunonephelometry of apolipoprotein A-II 601
J. Clin. Chem. Clin. Biochem.
Vol. 27, 1989, pp. 601-604
© 1989 Walter de Gruyter & Co.
Berlin · New York
Immunonephelometric Determination of the Apolipoprotein A-II
By G. Hafner, C. Luley, and W. Prellmtz
Institutf r Klinische Chemie und Laboratoriumsmedizin der Johannes Gutenberg-Universit t Mainz, FRG
(Received January 6/May 29, 1989)
Summary: A fully mechanized immunonephelometric method is described for the rapid and specific deter-
mination of apolipoprotein A-II in serum. The method utilizes commercially available sheep antiserum against
human apolipoprotein A-II. Nephelometry was performed with the Behring Nephelometer Analyzer (BNA).
A single determination can be performed in 12 minutes, requiring 10 μΐ sample volume. The measuring r nge
is about 0.08 to 1.25 g/l apolipoprotein A-II. Precision is characterized by intra-assay coefficients of Variation
of 3.37%, 3.93% and 4.49% for apolipoprotein A-II concentrations of 1.22 g/l, 0.376 g/I and 0.185 g/l, and
inter-assay coefficients of Variation of 4.27% for an apolipoprotein A-II concentration of 0.404 g/l, respectively.
Accuracy of the method is shown by the close correlation of results with those from radial immunodiffusion
(r = 0.913, y = 1.091 χ - 0.033, n = 75).
Introduction
HDL-lipoproteins are very important plasma lipopro-
teins, which provide protection against premature ar-
teriosclerosis. Furthermore, the HDL concentration
and the apolipoprotein profile are useful diagnostic
aids in certain illnesses (1). This not only applies to
the rare Tangier disease (2), but also to cholestasis (3)
and the different forms of myeloma (4). The concen-^
tfati n of apolipoprotein A-II seems to be specifically
helpful s an indicator of alcohol abuse (5), and in
the diagnosis of cirrhosis and neoplasms of the liver
(6).
Numerous methods for measuring apolipoprotein Α-
Ι have been described which c ii b.e sed by both
research and routine laboratories. In contrast, there
are relatively few methods for apolipoprotein A-II
(the second most common HDL protein), which per-
mit the determination of a reasonably large number
of samples automatically and with a large measuring
r nge. This paper describes the use of a fully auto-
matic nephelometer combined with commercially
available sheep antiserum which satisfies these re-
quirements.
Materials and Methods
The antiserum used is a commercially available sheep antiserum
against human apolipoprotein A-II (Boehringer, Mannheim,
FRG). When the monospecificity of this antiserum was exam-
ined by the immuiioprecipitation of focussed HDL-apolipopro-
teins (7), only a single precipitation line, i. e. the famili r apo-
lipoprotein A-II band, was formed. The following parameters
were used for the Operation of the Behring Nephelometer Ana-
lyzer (BNA; Behring, Marburg, FRG):
sample volume:
sample dilution:
antiserum volume:
reagent 2-volume:
(N-additional reagent/
precipitation)
re ction buffer volume:
measuring time:
10 μΐ
1:20
20 μΐ
10 μΐ
2 χ 100 μΐ
12 min (fixed time)
A commercial Standard (Immuno, Heidelberg, FRG) was used
to calibrate the nephelometer. Precision control was carried out
with the N-apolipoprotein Standard serum (Behring, Marburg,
FRG). As buffer System the N-reaction buffer (Behring, Mar-
burg, FRG) was used. To suppress any non-specific secondary
reacti ns, the N-additional reagent/precipitation (Behring,
Marburg, FRG) was used. All sample dilutions were accom-
plished with the N-diluent (Behring, Marburg, FRG). Lipaemic
samples were pre-treated according to the manufacturer's in-
structions with lipoclean (Behring, Marburg, FRG).
Apolipoprotein A-II determination with radial immunodifiu-
sion (RID) was carried out according to the manufacturer's
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instructions (Iramuno, Heidelberg, FRG). The RIO Reference
Standard Apoproteins human (Immuno, Heidelberg, FRG)
were used to compile the calibration curve.
The sample material used was serum without further prelimi-
nary treatment.
Results
The commercially available, monospecific antiserum
is suitable for antigen determining tests with immu-
nochemical methods, but it is not specially prepared
for nephelometry. The precipitation is shown in figure
1. The curve obtained with the fixed-time-method
shows that, in the case of this measuring method, the
terminal point of the reaction has still not been
reached after a period of 30 minutes. However, in the
present method, the terminal point does not have to
be reached, and measurements can be made towards
3000 p
Fig. 1. Greatest diffused light signal produced during calibra-
tion of five different measuring times with minimum
dilution of the Standard for apolipoprotein A-II (l: 5)
(Calibration l Δ , Calibration 2 χ ) and apolipo^
protein A-I (l: 5) ( α )
4 5 6 7 8 9 ΙΟ'2 2 3 6 5 6 7
Apolipoprotein A-Π Standard concentration Cg/l]
Fig. 2. Calibration curve of the apolipoprotein A-II with the
Behring Nephelometer Analyzer. The apolipoprotein Α-
Π concentrations of the Standard dilutions (geometric
- dilution series from l: 5 to l: 80 of a Standard concen-
tration of 0.312 g/l) and the intensity of the scattered
light signal are shown. The figures given in % are the
deviations from the curve calculated by the Behring
Nephelometer Analyzer.
the end of the reaction (about 80 — 90 percent of
maximum precipitation should be achieved). This
antiserum can therefore be used with this Instrument
for the nephelometric determination of the apolipo-
protein A-II with a measuring time of 12 minutes.
For comparison, the Illustration shows the precipi-
tation time curve of an antiserum specified for the
nephelometric determination of 'apolipoprotein A-I
(Behring, Marburg, FRG).
A representative calibration curve in figure 2 shows
the measuring signal which is dependent on the an-
tigen concentration. Here, the measuring r nge is
between 0.08 g/l and 1.25 g/l with a sample dilution
of 1:20.
In an attempt to reduce cost$ by decreasing the
amount of antiserum to 15 μΐ or even 10 μΐ, the
resulting turbidity was no longer sufficient to produce
a tilizable measuring signal for the lowest measuring
point. Evidently this is due to formation of soluble
antigen-antibody complexes at low antigen concen-
tration. This would mean that the measuring scale
would only r nge from 0.16 g/l to 1.25 g/l. Sinee
measurement values around 0.2 g/l are not uncom-
mon, an antiserum quantity of 20 μΐ was selected to
give greater accuracy in this r nge.
At the recommended sample dilution, the measuring
r nge embraces the normal r nge and the pathologi-
cally low r nge down to about 0.08 g/l. The linear
course followed by the c rves over the whole of the
measuring r nge in figure 3 shows that the diluti ii
or the automatic post-dilution of the samples by the
Instrument do not produce distorted values.
The precision of the method was verified by deter-
mining the within-series imprecision, and between-
series imprecision. The results of the assays carried
out with various pool serums are given in table 1.
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Fraction of maximum concentration
Fig. 3. Apolipoprotein A-II on the Be ring Nephelometer Ana-
lyzer. Linearities in a low ( V ) (y = 0.00 6x - 0.015)
- and in a high r nge ( Δ ) (y = 0.028 χ - 0.09)
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Tab. l. Precision of the irnmunonephelometric apolipoprotein
A-II determination
Within series
Between series
Apolipoprotein
A-II concen-
tration [g/l]
0.185
0.376
1.122
0.404
Impre-
cision
[CV, %]
4.49
3.93
3.37
4.27
N um her
of
samples
20
20
20
15
1.0
Ό
J 0.8
α
S 0.6
Β
< 0.4
"ω
0.2
l
0.2 0.4 0.6 0.8 1.0
Apolipoprotein Α-Π (immunonephelometric method) Lg/l]
Fig. 4. Method comparison for apolipoprotein A-II determi-
nation in patient samples by the Behring Nephelometer
Analyzer (abscissa) and by RID (ordinate): The linear
regression function is y = 1.091 χ — 0.003; the coeffi-
cient of correlation is r = 0.913; the number of samples
are n = 75
2.00,-
0.80 1 2 3 4 5
Chylomicron triacylglycerols Lg/U
Fig. 5. Influence of chylomicrons on turbidity measurement.
The graph shows the deviatipn of values for apolipo-
protein Α-Π ( x ) and IgA ( V ) after preliminary
treatment with lipoclean, and apolippprotein A-II ( p )
. and IgA ( Δ ) withput lipoclean treatment, from the
values for chylomicron-free samples with increasing ad-
dition of triacylglycerol-bearing serum.
The high level of accuracy aehieved in all concentra-
tion ranges permits each analysis to be carried out s
a single determination. The accuracy of the method
was checked by comparison with radial immunodif-
fusion. Comparison of the results (fig. 4) shows close
agreement of the methods, r = 0.913 (Bablok &
Passing).
The influence of lipaemic samples on the nephelo-
metric determination of apolipoprotein A-II, before
and after treatment with lipoclean is shown in figure
5. Increasing quantities of chylomicrons (triacylgly-
cerol values up to 7 g/l) were added to the serum.
Haemolytic, icteric and heparinized samples displayed
no influence on the apolipoprotein A-II assays. Sam-
ples can be frozen for months or kept cool at 4 °C to
8 °C for a week until the determination is carried out.
Discussion
Despite the fact that the apolipoproteins of HDL are
present in structural complexes with lipids, they can
be determined quantitatively by conventional immu-
nological techniques without further processing (8, 9).
Although the antigenic determinants of apolipopro-
tein A-II in particular are masked by the protein-lipid
bond inside the HDL (10), delipidation with organic
solvents is not necessary (11). Haemolytic, icteric and
heparinized samples do not interfere in nephelometric
determinations. Only strongly lipaemic sera with a
large proportion of chylomicrons can lead to non-
specific turbidity. In this case preliminary treatment
and chylomicron-free transfer of the samples into the
sample vessels of the nephelometer are neccessary. If
the test is performed with a highly diluted sample
(l: 20), and additional reaction/precipitation, which
suppresses non-specific turbidity, preliminary treat-
ment with lipoclean is not neccessary up to triacyl-
glycerol values of 7 g/l).
Apart from a commercially available Standard, the
method described also uses a commercially available,
monospecific antiserum and can be carried out with
a nephelometer of the type used for clinical chemical
work in routine laboratories. Since no more than 20
μΐ of antiserum is required for the test, the costs
remain at a reasonable level. In addition to the high
level of automation, this measuring method also has
a very wide measuring r nge from about 0.1 g/l to
over 2.5 g/l. Thus it is clearly superior to immuno-
turbidimetry, which has a working r nge of 0.25 —
0.99 g/l (8), 0.207-0.83 g/l (9) or 0.075-0.3 g/l (11).
Likewise the effective measuring r nge of 0.14—1.14
g/l, which can be aehieved with an enzyme-linked
immunoabsorbent assay (12), is smaller. The high
level of precision expected with automated methods
is easily aehieved (tab. 1). Comparison with the RID
values also shows good agreement (r = 0.913). The
immunoturbidimetric methods require measuring
times of 12.5 minutes (9), 25 minutes (11) and 60
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minutes (8), which facilitate a high sample through-
put. With a measuring time of 12 minutes, the ne-
phelometric method described is thus one of the
quiekest determination procedures for apolipoprotein
A-II.
In summary, a routine procedure for apolipoprotein
A-II has been established, using the Behring Nephe-
lometer Analyzer, combined with a commercial anti-
serum and a commercial Standard and controls. The
advantages, compared with other methods, are the
high sample throughput and its very wide measuring
ränge.
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